首页> 美国卫生研究院文献>Cancer Cell International >Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers
【2h】

Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers

机译:雌激素代谢蛋白的氧化还原调节受损是人类乳腺癌的重要决定因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Estrogen evidently involves critically in the pathogenesis of gynaecological-cancers. Reports reveal that interference in estrogen-signalling can influence cell-cycle associated regulatory-processes in female reproductive-organs. The major determinants that influence E2-signallings are estrogen-receptor (ER), estrogen-sulfotransferase (SULT1E1), sulfatase (STS), and a formylglycine-generating-enzyme (FGE) which regulates STS activity. The purpose of this mini review was to critically analyze the correlation between oxidative-threats and redox-regulation in the process of estrogen signalling. It is extensively investigated and reported that oxidative-stress is linked to cancer. But no definite mechanism has been explored till date. The adverse effects of oxidative-threat/free-radicals (like genotoxic-effects, gene-regulation, and mitochondrial impairment) have been linked to several diseases like diabetes/cardiovascular-syndrome/stroke and cancer. However, a significant correlation between oxidative-stress and gynaecological-cancers are repeatedly reported without pointing a definite mechanism. For the first time in our study we have investigated the relationship between oxidative stress and the regulation of estrogen via estrogen metabolizing proteins. Reports reveal that ER, SULT1E1, STS and FGE are target-molecules of oxidative-stress and may function differently in oxidizing and reducing environment. In addition, estrogen itself can induce oxidative-stress. This fact necessitates identifying the critical connecting events between oxidative-stress and regulation of estrogen-associated-molecules (ER, SULT1E1, STS, and FGE) that favors tumorigenesis/carcinogenesis. The current review focus is on unique redox-regulation of estrogen and its regulatory-molecules via oxidative-stress. This mechanistic-layout may identify new therapeutic-targets and open further scopes to treat gynecological-cancers more effectively.
机译:雌激素显然与妇科癌症的发病机理有关。报告显示,干扰雌激素的信号可能影响女性生殖器官中与细胞周期相关的调节过程。影响E2信号传递的主要决定因素是雌激素受体(ER),雌激素磺基转移酶(SULT1E1),硫酸酯酶(STS)和调节STS活性的甲酰基甘氨酸生成酶(FGE)。本次迷你回顾的目的是严格分析雌激素信号传导过程中氧化威胁与氧化还原调节之间的相关性。广泛研究并报道了氧化应激与癌症有关。但是到目前为止,还没有确定的机制被探索。氧化威胁/自由基的不利影响(如遗传毒性作用,基因调节和线粒体损伤)已与糖尿病/心血管综合征/中风和癌症等多种疾病相关。然而,反复报道氧化应激与妇科癌症之间的显着相关性,而没有指出明确的机制。在我们的研究中,我们首次研究了氧化应激与通过雌激素代谢蛋白调节雌激素之间的关系。报告显示,ER,SULT1E1,STS和FGE是氧化应激的目标分子,在氧化和还原环境中可能发挥不同的作用。另外,雌激素本身可以诱导氧化应激。这一事实有必要确定氧化应激与雌激素相关分子(ER,SULT1E1,STS和FGE)的调节之间的关键联系事件,这些事件有利于肿瘤发生/致癌作用。当前的审查重点是通过氧化应激对雌激素及其调节分子进行独特的氧化还原调节。这种机制布局可以确定新的治疗目标,并为进一步有效治疗妇科癌症开辟新的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号